首页> 外文期刊>Journal of clinical gastroenterology >Acute upper gastrointestinal bleeding in patients with liver cirrhosis and in noncirrhotic patients: epidemiology and predictive factors of mortality in a prospective multicenter population-based study.
【24h】

Acute upper gastrointestinal bleeding in patients with liver cirrhosis and in noncirrhotic patients: epidemiology and predictive factors of mortality in a prospective multicenter population-based study.

机译:肝硬化患者和非肝硬化患者的急性上消化道出血:一项基于前瞻性多中心人群研究的流行病学和死亡率预测因素。

获取原文
获取原文并翻译 | 示例
           

摘要

GOALS: To assess epidemiologic features and predictive factors of mortality of acute upper gastrointestinal bleeding (UGIB). STUDY: During a 6-month period, a prospective population-based study including all the UGIB occurring in a geographic area of 3 million people was conducted. Data from cirrhotic patients were compared with those of noncirrhotic patients. RESULTS: A total of 2,133 UGIB were recorded, 21.9% in cirrhotic patients (n = 468). Endoscopic hemostasis was performed in 46.5% and 8.3% in cirrhotic and noncirrhotic patients, respectively (P < 0.001). Mortality during hospitalization was 23.5% in cirrhotic patients and 11.2% in noncirrhotic patients (P < 0.001). Six independent predictive factors of mortality were observed in both patient groups: a prothrombin level less than 40%, an UGIB occurring in inpatients, a concomitant digestive carcinoma, a hematemesis revealing the UGIB, a recent use of steroid drugs, and age over 60 years. Four other predictive factors of mortality were also identified in noncirrhotic patients. CONCLUSIONS: Although epidemiologic features, clinical course, management, and prognosis of UGIB were quite different in cirrhotic and noncirrhotic patients, the majority of predictive factors of mortality were the same in both patient groups. These data underline the major role of debilitated status and hepatic failure in the prognosis of UGIB in cirrhotic patients.
机译:目标:评估急性上消化道出血(UGIB)的流行病学特征和死亡率的预测因素。研究:在六个月的时间里,进行了一项基于人群的前瞻性研究,包括在300万人的地理区域中发生的所有UGIB。将肝硬化患者的数据与非肝硬化患者的数据进行比较。结果:总共记录到2133 UGIB,其中21.9%在肝硬化患者中(n = 468)。肝硬化和非肝硬化患者的内镜止血率分别为46.5%和8.3%(P <0.001)。肝硬化患者的住院期间死亡率为23.5%,非肝硬化患者的死亡率为11.2%(P <0.001)。在两个患者组中均观察到六个独立的死亡率预测因素:凝血酶原水平低于40%,住院患者发生UGIB,伴随消化道癌,显示UGIB的呕血,最近使用类固醇药物以及年龄超过60岁。在非肝硬化患者中还确定了死亡率的其他四个预测因素。结论:尽管在肝硬化和非肝硬化患者中,UGIB的流行病学特征,临床病程,治疗和预后均存在很大差异,但两组患者的大多数死亡预测因素相同。这些数据强调了衰弱状态和肝衰竭在肝硬化患者UGIB预后中的重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号